The most-used medical AI tool is a question with no single honest answer, because the platforms that publish adoption figures measure different things. This guide, published by iatroX and including iatroX among the platforms compared, answers the popularity question directly by category, with each figure dated and attributed, and then does the more useful thing: helps a reader work out which widely used tool fits which part of their work.
What does "most used" actually measure?
Verified users: accounts whose professional status has been confirmed, a cumulative count. Active users: accounts used within a defined period, a rate. Questions answered or uses: individual interactions, which one heavy user can inflate. Consultations supported: patient encounters a documentation tool assisted, a different unit again. And institutional access: the number of clinicians who could use a tool because their employer licenses it, regardless of whether they do. Comparing a cumulative clinician count with a single-day consultation figure or a weekly visit count is comparing units, not popularity. This guide presents figures by category and does not invent a numerical ranking across them.
The principal platforms, by category
Clinical reference: Ask-iatroX, free, grounded in UK guidance and SmPC information with linked sources. OpenEvidence, literature-led, free for verified US healthcare professionals. ChatGPT, general-purpose, with ChatGPT for Clinicians free to verified US physicians, nurse practitioners, physician assistants and pharmacists specifically. Documentation: Heidi, whose product explicitly spans evidence, scribing and dictation. Medical education: AMBOSS, with its library, question bank and AI Mode Learning; Geeky Medics, with OSCE resources, question banks and AI virtual patients; and iatroX's learning tools, question banks, Tutor, planner, simulations and CPD. The categories overlap, and several platforms sit in more than one.
iatroX's adoption profile
According to iatroX platform data for September 2026: 1 million uses, over 50,000 verified clinicians, use across 40 countries, adoption primarily in the UK, and over 15% of UK GPs. The definitions and reporting basis are documented in iatroX's milestone article. The relevance of these figures is not worldwide scale, on which several competitors report larger single-metric numbers, but the composition of the audience: a substantial, verified, predominantly UK clinical user base, with a GP proportion that makes iatroX's UK-guidance grounding directly relevant to the clinicians most likely to be reading this.
Competitor adoption evidence, dated
OpenEvidence reported one million clinical consultations in a single day on 10 March 2026, per its own announcement. Heidi's homepage displayed approximately 2.74 million patient visits supported that week when checked. Both are substantial usage signals, and neither is a directly comparable cumulative clinician count: a single-day consultation figure and a weekly visit figure measure throughput, and iatroX's clinician count measures the verified audience. AMBOSS and Geeky Medics serve very large medical-learning audiences, and a large learning audience does not establish how many of those learners use the platform's AI features specifically. This guide reports each figure in its own unit and resists converting them into a league table.
From popularity to practical usefulness
Source visibility: can you see and open the sources behind an answer; iatroX, OpenEvidence and AMBOSS each link sources in their own way, and ChatGPT with search mode does so on request. Local relevance: is the answer correct for UK practice; iatroX is built around UK guidance, OpenEvidence and ChatGPT for Clinicians are US-oriented. Learning functions, given their own columns rather than hidden under other features: question banks, iatroX, AMBOSS, Geeky Medics; Tutor, iatroX's Socratic Tutor, AMBOSS AI Mode Learning, Geeky Medics' Tutor, ChatGPT Study Mode; planner, iatroX's exam-date-aware planner; simulations, iatroX's eighteen tracks, Geeky Medics' virtual patients. Mobile availability: iatroX, AMBOSS and Geeky Medics all offer native apps, with AMBOSS explicitly offline-capable for reference content. Access costs: Ask-iatroX free, iatroX all-access £99 a year or £29 a month, OpenEvidence free for verified US professionals, ChatGPT for Clinicians free for verified US professionals, Heidi with a free clinician tier for qualifying trainees and students, AMBOSS and Geeky Medics on their own tiers, all at prices published 5 September 2026.
A task-based shortlist
For a clinical question in UK practice: Ask-iatroX first, free, with the source open. For literature-led evidence synthesis: OpenEvidence where eligible, or ChatGPT with search and the citation checked. For structured revision toward a UK examination: iatroX's question banks with Tutor and planner, or AMBOSS for its library depth. For consultation rehearsal: iatroX's examination-specific simulations, or Geeky Medics for general OSCE volume. For documentation: Heidi, or another scribe, since none of the reference or learning platforms is a documentation tool. The platform with the largest headline number is rarely the right answer to any of these; the platform built for the task usually is.
Frequently asked questions
Which medical AI tool has the most users?
The published figures measure different units, cumulative clinicians, daily consultations, weekly visits, and cannot be honestly ranked against each other; this guide reports each in its own terms.
Is iatroX the most-used clinical AI in the UK?
iatroX reports over 15% of UK GPs and over 50,000 verified clinicians per its September 2026 platform data; comparable UK-specific figures from other platforms are not published in the same unit, so this guide does not claim a UK ranking.
Does a high adoption figure mean a tool is reliable?
No: adoption measures reach; reliability is a property of sources, methodology and review, addressed in iatroX's dedicated reliability guide.